NEWS & UPDATES

February 14, 2018

  • Glatopa® 40 mg/mL is a fully substitutable, AP-rated generic version of Copaxone®* (glatiramer acetate injection) 40 mg/mL

  • Glatopa 40 mg/mL, along with Glatopa® 20 mg/mL, which was launched in the US in June 2015, will offer patients a complete range of dosing options

  • A full range of patient support services for Glatopa® is available through...

February 12, 2018

Goal is to improve U.S. employee satisfaction while reducing overall costs

SEATTLE & OMAHA, Neb. & NEW YORK--(BUSINESS WIRE)--Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B) and JPMorgan Chase & Co. (NYSE: JPM) announced today that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee...

Please reload

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon
  • Black Google+ Icon